Alnylam Pharmaceuticals Inc (ALNY)
245.50
+6.63
(+2.78%)
USD |
NASDAQ |
Dec 20, 16:00
245.46
-0.04
(-0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Shareholders Equity (Quarterly): 32.35M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| BridgeBio Pharma Inc | -1.230B |
| Gilead Sciences Inc | 18.47B |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Sarepta Therapeutics Inc | 1.221B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.205B |
| Total Liabilities (Quarterly) | 4.173B |
| Debt to Equity Ratio | 31.64 |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |